Chemours (CC) PT Lowered to $14 at RBC Capital
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $15.39 -3.63%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $14.00 (from $17.00) while maintaining a Outperform rating.
You May Also Be Interested In
- XPeng (XPEV) PT Lowered to $15 at US Tiger Securities
- Emerson (EMR) PT Raised to $155 at DA Davidson, Neutral Rating Maintained
- SL Green Realty (SLG) PT Raised to $57 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
